INS and Alzheimer disease: Additionally, in AD, the impaired brain insulin signaling may contribute to cognitive decline via impaired hippocampal neuroplasticity, increased tau protein concentration, neuroinflammation and mitochondrial dysfunction(Biessels and Reagan, 2015).